We confirmed that only the ER+ MCF7 and HCC1500 cell lines express GFRα1, raising the expectation that our GFRα1-specific oHSV will seek out a distinct subtype of breast cancer cells than the previously developed HER2-retargeted oHSVs. Here, ERBB2 is linked to breast carcinoma.